We will review the existing technologies and outline the potential for the targeted application. An important aspect will be the filament-based 3D printing technology. A case study will be presented on how a hot-melt extrusion process can be optimized for filament production. Material properties, as well as downstream equipment, drive a successful implementation. We will also present a novel melt-based 3D printing approach, which can directly create the final dosage form out of powder. A drop-based deposition of the polymer melt ensures a new level of accuracy and individualization when it comes to the finishing of the final form.
In this webinar you will learn about:
Thomas Kipping, Ph.D.
Head of Drug Carriers
With a broad expertise in the field of solid dosage forms, Dr. Thomas Kipping provides a deep understanding of formulation development and process optimization in the complex area of solubility enhancement. He has a strong background in pharmaceutical industry, including industrial development, GMP manufacturing, clinical supply and research & development. Thomas is a pharmacist by education and holds a Ph.D. in Pharmaceutical Technology.